JNCI Journal of the National Cancer Institute

EDITORIALS

R Narayanan

Harnessing the power of antisense technology for combination chemotherapy
J. Natl. Cancer Inst. 1997 89: 107; doi:10.1093/jnci/89.2.107 [PDF]  

D Feldman

Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk
J. Natl. Cancer Inst. 1997 89: 109. [PDF]  

NEWS

T Reynolds

Photodynamic therapy expands its horizons
J. Natl. Cancer Inst. 1997 89: 112; doi:10.1093/jnci/89.2.112 [PDF]  

C Bankhead

Bisphosphonates spearhead new approach to treating bone metastases
J. Natl. Cancer Inst. 1997 89: 115.  

S Steimle

NPCC unifies prostate cancer advocates
J. Natl. Cancer Inst. 1997 89: 117.  

S Jenks

Gene therapy group agrees to smaller size, less authority
J. Natl. Cancer Inst. 1997 89: 118.  

H McIntosh

For women smokers, the gender gap is narrowing
J. Natl. Cancer Inst. 1997 89: 120.  

J Ziegler

"Sweet sixteen" drugs blur line between treatment, prevention
J. Natl. Cancer Inst. 1997 89: 121.  

ARTICLES

T Skorski, M Nieborowska-Skorska, P Wlodarski, D Perrotti, G Hoser, J Kawiak, M Majewski, L Christensen, RV Iozzo, and B Calabretta

Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides
J. Natl. Cancer Inst. 1997 89: 124; doi:10.1093/jnci/89.2.124 [Abstract] [PDF]  

RJ Henderson, JA Eastham, DJ Culkin, MW Kattan, T Whatley, J Mata, D Venable, and O Sartor

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer
J. Natl. Cancer Inst. 1997 89: 134; doi:10.1093/jnci/89.2.134 [Abstract] [PDF]  

G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, I Matsubara, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, and T Tominaga

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
J. Natl. Cancer Inst. 1997 89: 139; doi:10.1093/jnci/89.2.139 [Abstract] [PDF]  

C Lerman, B Biesecker, JL Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, and MM Reed

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing
J. Natl. Cancer Inst. 1997 89: 148; doi:10.1093/jnci/89.2.148 [Abstract] [PDF]  

DJ Grignon, R Caplan, FH Sarkar, CA Lawton, EH Hammond, MV Pilepich, JD Forman, J Mesic, KK Fu, RA Abrams, TF Pajak, WU Shipley, and JD Cox

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610
J. Natl. Cancer Inst. 1997 89: 158; doi:10.1093/jnci/89.2.158 [Abstract] [PDF]  

SA Ingles, RK Ross, MC Yu, RA Irvine, G La Pera, RW Haile, and GA Coetzee

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
J. Natl. Cancer Inst. 1997 89: 166; doi:10.1093/jnci/89.2.166 [Abstract] [PDF]  

CORRESPONDENCE

GF Fleming, SE Waggoner, S Wu, J Rotmensch, and BA Conley

Re: Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a
J. Natl. Cancer Inst. 1997 89: 172. [PDF]  

C Monnerat, M Gander, and S Leyvraz

A rare case of prednimustine-induced myoclonus
J. Natl. Cancer Inst. 1997 89: 173; doi:10.1093/jnci/89.2.173 [PDF]  

B Brandt, C Griwatz, O Brinkmann, and KS Zanker

Circulating prostate-specific antigen/CD14-double-positive cells: a biomarker indicating low risk for hematogeneous metastasis of prostate cancer
J. Natl. Cancer Inst. 1997 89: 174; doi:10.1093/jnci/89.2.174 [PDF]  

M Raderer, G Kornek, G Weinlander, and J Kastner

Serum troponin T levels in adults undergoing anthracycline therapy
J. Natl. Cancer Inst. 1997 89: 171. [PDF]  

P McCarthy

Re: Healthy People 2000 review: women's cancers
J. Natl. Cancer Inst. 1997 89: 171. [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.